Pharmafile Logo

Redefining digital ROI: Engagement, experience, and the new metrics of success

December 18, 2025 | Engagement, RoI, experience 

Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional KPIs to measure real impact and ROI from digital and omnichannel initiatives.

- PMLiVE

As pressure grows on pharma teams to prove the value of their digital initiatives, traditional KPIs are falling short. Engagement rates and click-throughs only tell part of the story. What matters now is meaningful impact – for your audience, and your business.

In this webinar, we explored how pharma teams can evolve their digital measurement frameworks to capture what really counts. We discussed why traditional KPIs fall short in today’s pharma landscape, how to link engagement and experience to real-world outcomes, what ROI really means for digital and omnichannel investment and how to build actionable, insight-led measurement frameworks.

Latief Ziada, from Graphite, was joined by two expert panellists — Alyssa Fenoglio, Global Head of Digital Commercial, Teva Pharmaceuticals, and Florent Edouard, Global Head of the Digital Accelerator, Sanofi.

If you’re involved in digital decision-making within pharma, check it out.

Disclaimer: The opinions shared by our panellists are solely their own and should not be taken as representative of their organisations.

This content was provided by Graphite Digital

Company Details

 Latest Content from  Graphite Digital 

Advancing digital engagement in pharma and healthcare: 2024 focus areas

6 areas for pharma and healthcare organisations to focus efforts in 2024 to drive better digital engagement amongst patients, HCPs and other users

Building trust with HCPs: 6 takeaways from our industry webinar

Key takeaways from the perspectives of industry experts across medical, commercial and digital on the issue of trust in pharma and how this impacts HCP engagement.

Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital

Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...

What are design systems and how can they help you elevate your digital products?

Design Systems aren’t new, but the potential to utilise them to improve the way in which teams produce digital products is still untapped for many in the pharmaceutical and healthcare...

The impact of mindset on digital product success: Download our new whitepaper

Six months on from releasing our research report, we reflect on the themes raised and offer practical advice on how contradictions can be overcome to enable digital success in pharma...

Demonstrating the value of UX research in pharma and healthcare

Demonstrating the value of UX research in pharma and healthcare can be difficult. Here, Graphite's Senior Clinical UX Researcher, Jack Burton, explains the importance of user research within the digital...

Overcoming challenges in digital pharma to get to launch quicker

We take a look at why it can take pharma businesses so long to get their digital products into the hands of patients or HCPs, and what can be done...

The Contradiction Conundrum: New digital pharma report

New research, based on the views of 450 pharma professionals, reveals contradictions in how pharma organisations are approaching their digital products and strategies.